These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
286 related articles for article (PubMed ID: 38276309)
1. Gut Microbiota-Gut Metabolites and Gurung B; Stricklin M; Wang S Metabolites; 2024 Jan; 14(1):. PubMed ID: 38276309 [No Abstract] [Full Text] [Related]
2. The role of the gut microbiome in colonization resistance and recurrent Seekatz AM; Safdar N; Khanna S Therap Adv Gastroenterol; 2022; 15():17562848221134396. PubMed ID: 36425405 [TBL] [Abstract][Full Text] [Related]
3. Butyrate Differentiates Permissiveness to Clostridioides difficile Infection and Influences Growth of Diverse C. difficile Isolates. Pensinger DA; Fisher AT; Dobrila HA; Van Treuren W; Gardner JO; Higginbottom SK; Carter MM; Schumann B; Bertozzi CR; Anikst V; Martin C; Robilotti EV; Chow JM; Buck RH; Tompkins LS; Sonnenburg JL; Hryckowian AJ Infect Immun; 2023 Feb; 91(2):e0057022. PubMed ID: 36692308 [TBL] [Abstract][Full Text] [Related]
4. Efficacy and Safety of RBX2660 in PUNCH CD3, a Phase III, Randomized, Double-Blind, Placebo-Controlled Trial with a Bayesian Primary Analysis for the Prevention of Recurrent Clostridioides difficile Infection. Khanna S; Assi M; Lee C; Yoho D; Louie T; Knapple W; Aguilar H; Garcia-Diaz J; Wang GP; Berry SM; Marion J; Su X; Braun T; Bancke L; Feuerstadt P Drugs; 2022 Oct; 82(15):1527-1538. PubMed ID: 36287379 [TBL] [Abstract][Full Text] [Related]
6. Host and microbial-derived metabolites for Clostridioides difficile infection: Contributions, mechanisms and potential applications. Gao Y; Ma L; Su J Microbiol Res; 2022 Oct; 263():127113. PubMed ID: 35841835 [TBL] [Abstract][Full Text] [Related]
7. Diluted Fecal Community Transplant Restores Clostridioides difficile Colonization Resistance to Antibiotic-Perturbed Murine Communities. Lesniak NA; Tomkovich S; Henry A; Taylor A; Colovas J; Bishop L; McBride K; Schloss PD mBio; 2022 Aug; 13(4):e0136422. PubMed ID: 35913161 [TBL] [Abstract][Full Text] [Related]
8. Shengjiang Xiexin decoction mitigates murine Clostridium difficile infection through modulation of the gut microbiota and bile acid metabolism. Yu XH; Lv Z; Zhang CE; Gao Y; Li H; Ma XJ; Ma ZJ; Su JR; Huang LQ J Ethnopharmacol; 2024 Feb; 320():117384. PubMed ID: 37925000 [TBL] [Abstract][Full Text] [Related]
9. Fecal microbiota transplantation for the treatment of recurrent Clostridioides difficile (Clostridium difficile). Minkoff NZ; Aslam S; Medina M; Tanner-Smith EE; Zackular JP; Acra S; Nicholson MR; Imdad A Cochrane Database Syst Rev; 2023 Apr; 4(4):CD013871. PubMed ID: 37096495 [TBL] [Abstract][Full Text] [Related]
11. Understanding the mechanisms of efficacy of fecal microbiota transplant in treating recurrent Martinez-Gili L; McDonald JAK; Liu Z; Kao D; Allegretti JR; Monaghan TM; Barker GF; Miguéns Blanco J; Williams HRT; Holmes E; Thursz MR; Marchesi JR; Mullish BH Gut Microbes; 2020 Nov; 12(1):1810531. PubMed ID: 32893721 [TBL] [Abstract][Full Text] [Related]
12. Gut associated metabolites and their roles in Aguirre AM; Sorg JA Gut Microbes; 2022; 14(1):2094672. PubMed ID: 35793402 [TBL] [Abstract][Full Text] [Related]
14. Microbial ecology between Kamiya S Biosci Microbiota Food Health; 2023; 42(4):229-235. PubMed ID: 37791342 [No Abstract] [Full Text] [Related]
15. The evaluation of fecal microbiota transplantation vs vancomycin in a Clostridioides difficile infection model. Xu Q; Zhang S; Quan J; Wu Z; Gu S; Chen Y; Zheng B; Lv L; Li L Appl Microbiol Biotechnol; 2022 Oct; 106(19-20):6689-6700. PubMed ID: 36085529 [TBL] [Abstract][Full Text] [Related]
16. Intestinal Inflammation Reversibly Alters the Microbiota to Drive Susceptibility to Clostridioides difficile Colonization in a Mouse Model of Colitis. Barron MR; Sovacool KL; Abernathy-Close L; Vendrov KC; Standke AK; Bergin IL; Schloss PD; Young VB mBio; 2022 Aug; 13(4):e0190422. PubMed ID: 35900107 [TBL] [Abstract][Full Text] [Related]
17. Domestic canines do not display evidence of gut microbial dysbiosis in the presence of Clostridioides (Clostridium) difficile, despite cellular susceptibility to its toxins. Stone NE; Nunnally AE; Jimenez V; Cope EK; Sahl JW; Sheridan K; Hornstra HM; Vinocur J; Settles EW; Headley KC; Williamson CHD; Rideout JR; Bolyen E; Caporaso JG; Terriquez J; Monroy FP; Busch JD; Keim P; Wagner DM Anaerobe; 2019 Aug; 58():53-72. PubMed ID: 30946985 [TBL] [Abstract][Full Text] [Related]
18. Longitudinal Bile Acid Composition Changes Following Faecal Microbiota Transplantation for Clostridioides difficile Infection in Children With and Without Underlying Inflammatory Bowel Disease. Chen LA; Oliva-Hemker M; Radin A; Weidner M; O'Laughlin BD; Sears CL; Javitt NB; Hourigan SK J Crohns Colitis; 2023 Aug; 17(8):1364-1368. PubMed ID: 36988432 [TBL] [Abstract][Full Text] [Related]
19. Faecal microbiota transplantation in the treatment of recurrent intestinal Clostridioides difficile infection - a ten-year single-center experience. Pipek B; Valentová H; Fojtík P; Urban O Cas Lek Cesk; 2022; 161(3-4):126-130. PubMed ID: 36100450 [TBL] [Abstract][Full Text] [Related]
20. Insights into the Role of Human Gut Microbiota in Kachrimanidou M; Tsintarakis E Microorganisms; 2020 Jan; 8(2):. PubMed ID: 32023967 [No Abstract] [Full Text] [Related] [Next] [New Search]